Amgen Inc sign letter intent estimate 75 mln dlr research development limited partnership fund clinical investigation pharmaceutical product currently development. Neither term arrangement nor product cover partnership disclose Amgen limited partnership unit include warrant purchase Amgen common stock. Reuter 